NextCell Pharma AB (FRA:65G)

NextCell Pharma AB Revenue

In the fiscal year ending August 31, 2025, NextCell Pharma AB had annual revenue of 11.06M SEK, down -1.90%. NextCell Pharma AB had revenue of 2.52M in the quarter ending August 31, 2025, with 48.67% growth.

• Revenue: 11.06M SEK
• Revenue Growth: -1.90%
• P/S Ratio: 13.77
• Revenue / Employee: 461.02K SEK
• Employees: 24
• Market Cap: 13.75M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	11.06M	-213.75K	-1.90%
Aug 31, 2024	11.28M	-2.68M	-19.18%
Aug 31, 2023	13.96M	7.73M	124.03%
Aug 31, 2022	6.23M	1.77M	39.82%
Aug 31, 2021	4.46M	288.92K	6.94%